APA

Fujita A., Yoh K., Shimohata H., Morito N., Ojima M., Okamura M., Takahashi S. & Yamagata K. (20120522). A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment. : Experimental animals.

Chicago

Fujita Akiko, Yoh Keigyou, Shimohata Homare, Morito Naoki, Ojima Masami, Okamura Midori, Takahashi Satoru and Yamagata Kunihiro. 20120522. A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment. : Experimental animals.

Harvard

Fujita A., Yoh K., Shimohata H., Morito N., Ojima M., Okamura M., Takahashi S. and Yamagata K. (20120522). A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment. : Experimental animals.

MLA

Fujita Akiko, Yoh Keigyou, Shimohata Homare, Morito Naoki, Ojima Masami, Okamura Midori, Takahashi Satoru and Yamagata Kunihiro. A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment. : Experimental animals. 20120522.